Market openNon-fractional

Eton Pharmaceuticals/ETON

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Eton Pharmaceuticals

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Ticker

ETON

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Deer Park, United States

Employees

30

ETON Metrics

BasicAdvanced
$90M
Market cap
106.95
P/E ratio
$0.03
EPS
1.19
Beta
-
Dividend rate
$90M
1.19
1.586
1.366
32.961
0.52%
1.24%
6.83%
106.95
2.63
5.75
9.78
27.907
40.71%
-113.02%
42.57%
-62.32%

What the Analysts think about ETON

Analyst Ratings

Majority rating from 1 analysts.
Buy

ETON Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-10.12% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$7.9M
8.22%
Net income
-$800K
-63.64%
Profit margin
-10.12%
-66.41%

ETON Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 57.14%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.18
-$0.02
-$0.09
-$0.03
-
Expected
-$0.09
-$0.10
-$0.04
-$0.07
-$0.07
Surprise
-300.00%
-80.00%
125.00%
-57.14%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Eton Pharmaceuticals stock?

Eton Pharmaceuticals (ETON) has a market cap of $90M as of July 23, 2024.

What is the P/E ratio for Eton Pharmaceuticals stock?

The price to earnings (P/E) ratio for Eton Pharmaceuticals (ETON) stock is 106.95 as of July 23, 2024.

Does Eton Pharmaceuticals stock pay dividends?

No, Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Eton Pharmaceuticals dividend payment date?

Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders.

What is the beta indicator for Eton Pharmaceuticals?

Eton Pharmaceuticals (ETON) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Eton Pharmaceuticals stock

Buy or sell Eton Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing